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Our understanding of protein evolution would greatly
benefit from mapping of binding landscapes, i.e.,
changes in protein-protein binding affinity due to all
single mutations. However, experimental generation
of such landscapes is a tedious task due to a large
number of possible mutations. Here, we use a simple
computational protocol to map the binding land-
scape for two homologous high-affinity complexes,
involving a snake toxin fasciculin and acetylcholines-
terase from two different species. To verify our
computational predictions, we experimentally mea-
sure binding between 25 Fas mutants and the 2
enzymes. Both computational and experimental re-
sults demonstrate that the Fas sequence is close to
the optimum when interacting with its targets, yet a
few mutations could further improve Kd, kon, and
koff. Our computational predictions agree well with
experimental results and generate distributions
similar to those observed in other high-affinity PPIs,
demonstrating the potential of simple computational
protocols in capturing realistic binding landscapes.
INTRODUCTION
Protein-protein interactions (PPIs) are crucial for all cellular
pathways, including signal transduction, DNA replication, tran-
scription/translation, and multicomponent protein assemblies.
Hence, understanding and manipulating PPIs is of high interest
for both basic biology and applied research, such as synthetic
biology and drug design. In the past decade, large effort has
been dedicated to characterizing PPIs at different levels. High-
throughput studies mapped all PPIs in several organisms,
accumulating extensive information on the architecture of PPI
networks and identifying new pairs of interacting proteins (Ito
et al., 2001; Uetz et al., 2000; Gavin et al., 2002; Giot et al.,
2003; Ho et al., 2002; Stelzl et al., 2005; Rual et al., 2005).
Constantly appearing high-resolution structures of protein-pro-
tein complexes facilitated atomic-level analysis of various bind-636 Structure 22, 636–645, April 8, 2014 ª2014 Elsevier Ltd All rightsing interfaces (Kastritis et al., 2011). Advances in molecular
biology allowed determination of single residue contribution to
the binding energetics (Pal et al., 2006). In spite of all this prog-
ress, our comprehension of the precise molecular forces that
govern binding affinity and binding specificity in PPIs remains
incomplete, impeding rational design of novel PPIs (Fleishman
et al., 2011a, 2011b).
A considerable number of experimental studies report
changes in free energy of binding (DDGbind) due to mutations.
However, the majority of such data involves substitutions to
Ala that destroy existing interactions, leading in most cases to
a decrease in PPI affinity (Cunningham and Wells, 1989, 1993;
Delano, 2002; Pal et al., 2005; Skelton et al., 2003; Yang et al.,
2003; Zhang and Palzkill, 2003) and providing no insight on
how to enhance binding affinity. In addition, mutations to Ala
rarely occur in nature and hence present marginal interest
when studying protein evolution. To obtain a more comprehen-
sive picture of binding interface evolution and architecture, one
should analyze changes in binding affinity due to all possible sin-
glemutations, thereby generating a PPI binding landscape. Such
landscapes can be used to estimate the degree of binding inter-
face sequence optimality and to identify affinity-enhancing
mutations that are important for various biotechnological appli-
cations (Pal et al., 2006). However, experimental generation of
binding landscapes is a tedious task due to the large number
of mutants that need to be constructed and assessed for binding
affinity. Hence, generation of binding landscapes through com-
putational means presents an attractive alternative to lengthy
experiments. Recent successes in predicting affinity-enhancing
mutations in various PPIs through structure-based computa-
tional methods (Selzer et al., 2000; Sammond et al., 2007; Haidar
et al., 2009; Reynolds et al., 2008; Hao et al., 2008; Lippow et al.,
2007) indicate that computational binding landscapesmight pro-
vide a good approximation to reality.
In this study, our goal was to generate a binding landscape for
a representative high-affinity PPI. Among various PPIs, high-
affinity PPIs are of particular interest because they are commonly
responsible for life and death decisions in the cell (such as, for
example, in immunity proteins-collicin interactions; Papadakos
et al., 2012). On the other hand, high-affinity PPIs are attractive
systems for computational biologists because they could be
used to learn about the nature of nearly optimal intermolecular in-
teractions such as packing, electrostatics, and hydrogen bondreserved
Figure 1. Structural Analysis of the Fas-
AChE Interface
(A) Structure of the Fas-hAChE complex (PDB ID
1B41). hAChE is shown in red, Fas is shown in
green. Binding interface residues are shown as
sticks (cyan on Fas and red on AChE).
(B) Results of the computational mutagenesis
experiments for Fas binding to tAChE (top) and
hAChE (bottom). Fas binding interface positions
with their WT identity are displayed on the left, the
mutated amino acid identity is on the top. Calcu-
lated DDGbind value for each mutation is color
coded from stabilizing (blue) to destabilizing (red).
Mutations selected for experimental analysis are
circled.
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affinity PPIs have evolved to perfection; hence, the majority of
mutations would lead to a decrease in binding affinity, whereas
beneficial mutations in the direct binding interface are rare,
making our task of finding such mutations a challenge.
As our model system, we picked a complex between an
essential synaptic enzyme acetylcholinesterase (AChE) and a
polypeptide toxin present in the venom of the green mamba
snake, fasciculin-2 (Fas). AChE terminates impulse transmission
at cholinergic synapses by rapid hydrolysis of a neurotrans-
mitter, acetylcholine (Zimmerman and Soreq, 2006). Fas is a
very powerful inhibitor of AChE, whose application leads to
muscle fasciculation and paralysis (Karlsson et al., 1985). High
affinity of the Fas-AChE complex (Kd of 10
121010 M; Weiner
et al., 2009; Radic et al., 1994; Eastman et al., 1995) is essential
for the snake’s ability to kill its prey.
Fas belongs to a three-finger toxin family that shares a com-
mon b sheet fold with three protruding loops or ‘‘fingers.’’ Four
disulfide bonds supply proteins in this family with very high sta-
bility (Kini, 2002). The high-resolution structures of Fas are avail-
able in complex with three different species of AChE: Mouse
(mAChE), Torpedo californica (tAChE), and Human (hAChE)
(Bourne et al., 1995; Harel et al., 1995; Kryger et al., 2000). All
three structures show a very similar binding mode where Fas
binds at the surface of the enzyme, sealing the access to the
AChE active site, which is buried in the middle of the enzyme
(Figure 1A). The tight binding between the two proteins has
been attributed to several factors, including high surface
complementarity, large hydrophobic surface burial, intermolec-
ular hydrogen bonds, and extremely optimized electrostatic
interactions between cationic residues on Fas and anionic resi-
dues on AChE (Harel et al., 1995; Radic et al., 1997).
In a previous study, we designed a quintuple Fas mutant with
the intention of improving its affinity to tAChE. Unfortunately, this
Fas mutant showed reduced affinity to the enzyme when
measured experimentally (Sharabi et al., 2009). Nevertheless,
we demonstrated that the decrease in affinity was mostly due
to one unsuccessfully predicted mutation, removal of which re-
sulted in slightly improved binding to the enzyme. To eliminate
the effect of error accumulation when dealing with multipleStructure 22, 636–645, April 8, 2014mutations, here we test our ability to pre-
dict the effect of single mutations at the
Fas binding interface. We first generatea computational binding landscape for Fas interacting with
AChE from two species, tAChE and hAChE. We then construct
a considerable number of Fas mutants experimentally and mea-
sure their binding affinities to both enzymes. We show that our
predictions are in good agreement with the experimental results
and demonstrate that whereas most mutations on the Fas bind-
ing interface lead to substantial reduction in affinity, a few muta-
tions result in significant affinity improvement.
RESULTS
Computational Saturated Mutagenesis of the Fas
Binding Interface
To determine how various mutations on Fas affect its binding
affinity to tAChE and hAChE, we performed computational satu-
rated mutagenesis (Sharabi et al., 2013) of the Fas binding inter-
face using the framework of the ORBIT protein design software
(Dahiyat and Mayo, 1997). Starting from the crystal structures
of Fas bound to tAChE and to hAChE, we considered 17 natural
amino acids at each of the Fas binding interface positions. We
did not consider mutations to Pro, Gly, and Cys because intro-
duction of Pro and Gly is likely to change Fas backbone confor-
mation, while Cys would interfere with the correct disulphide
bond formation of the protein. After each mutation was intro-
duced into Fas, we calculated the intermolecular energy DEinter
by subtracting the energies of the unbound chains from that of
the Fas-AChE complex. DDGbind was calculated as the differ-
ence between DEinter of the mutant and that of the wild-type
(WT) complex. In our calculations, we did not model backbone
flexibility, assuming that single mutations in Fas do not change
its fold significantly. Side chain flexibility was modeled by re-
packing side chains in the immediate vicinity of the mutation
site for the complex structure only. For the unbound chains,
side chain conformations were ‘‘frozen’’ in the conformation
determined for the complex structure (see Experimental Proce-
dures for more details).
The results of the computational saturated mutagenesis are
summarized in Figure 1B. Our results show that relatively few
mutations are predicted to improve Fas affinity to tAChE and
even fewer mutations to hAChE. This is consistent with ourª2014 Elsevier Ltd All rights reserved 637
Figure 2. Changes in Binding Free Energy,
Kinetic Rates, and Binding Specificity due
to Mutations on Fas
Parameters for interactions between Fas mutants
and tAChE are shown as gray bars and between
Fas mutants and hAChE are shown as black bars.
(A) Changes in DDGbind relative to WT Fas. Hori-
zontal lines at ± 0.4 kcal/mol distinguish mutations
with significant changes in DDGbind from those
with small changes in DDGbind.
(B) Enhancement in kon relative to WT Fas.
(C) Enhancement in koff relative to WT Fas. It was
not possible to obtain kinetic data for interactions
between tAChE and several mutants (T9N, R27M,
R27F, and R27Y) due to very fast association and
dissociation phases.
(D) Binding specificity of a particular Fas mutant to
tAChE (gray bars) and to hAChE (black bars).
Binding specificity is calculated as a ratio of Kd for
one enzyme species versus another.
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optimized. For some of the mutations, improvement in intermo-
lecular energy was coupled to significant destabilization of Fas
in the unbound form (Table S1 available online). We thought
that such Fas mutants are unlikely to show improved binding
in reality, but chose three of these mutants for experimental
validation.
Overall, we selected 23 Fas singlemutants (Figure 1B) and two
double mutants incorporating mutations at positions 8 and 9 for
testing. Among the 25 mutants, six were predicted to signifi-
cantly improve Fas affinity for tAChE and/or hAChE, and five
were predicted to significantly decrease affinity to both en-
zymes. Eleven of the selected mutants were predicted to
improve binding specificity toward one of the enzymes. The
number of Fas mutants being tested was limited by a relatively
tedious procedure for expression of this protein. Fas is a difficult
protein to express due to its small size and the presence of four
disulfide bonds. Indeed, when expressed in Escherichia coli and
in yeast (Pichia pastoris) using various protocols, no active pro-
tein was obtained. In our previous work however, we reported
an efficient protocol for Fas refolding after its expression in
E. coli (Sharabi et al., 2009). We used the same protocol for
expression and refolding of all the Fas mutants considered in
this work. The majority of the Fas mutants were refolded
correctly using a protocol designed for WT Fas. However, three
Fas mutants (M33W, V34N, and L35R) remained unfolded and
were hence excluded from further experiments (Figure S1).
To measure binding between the Fas mutants and tAChE/
hAChE, we used an enzyme activity assay that is based on color-
imetric detection of the AChE catalysis product. Very tight affin-
ities of Fas mutants to the enzyme could be measured using this
method due to high sensitivity of the assay. Moreover, the
enzyme-activity-based method allowed us to determine not
only the equilibrium binding affinities (Kd), but also the kinetic
rates, kon and koff (Figure S2).638 Structure 22, 636–645, April 8, 2014 ª2014 Elsevier Ltd All rights reservedUsing the above assay, we explored
the binding landscape of the Fas-AChE
interaction at physiological ionic strength
(I = 0.15 M). Fas WT binds to tAChE andhAChE with 370 pM and 90 pM affinities, preferring the Human
enzyme by about a factor of four. Figure 2A summarizes our
binding experiments where affinities between Fas mutants and
both tAChE and hAChE weremeasured. We assigned our exper-
imental DDGbind data to three different groups: mutations that
exhibit significant enhancement in affinity to one or both en-
zymes (DDGbind < 0.4 kcal/mol), mutations that nearly do not
change affinity (0.4 < DDGbind < 0.4 kcal/mol), and mutations
that significantly destabilize the complex between the Fas
mutant and either enzyme (DDGbind > 0.4 kcal/mol). We identified
five data points with significant enhancement in DDGbind. These
points belong to two Fas mutants H29R and H29K that show
improvement in affinity to both tAChE and hAChE and N47R
that shows improvement in affinity to only tAChE (Figure 2A
and Table 1). Our best affinity-improving mutation H29R, shows
12-fold affinity enhancement to 30 pM for tAChE while the sec-
ond best mutation, H29K, shows 4.5-fold affinity improvement
to 21 pM for hAChE. Ten data points fell in the neutral zone,
showing slight changes in binding affinity to one or both
enzymes, corresponding to mutants T8V/T9I, T8V/T9N, T9I,
K32R, N47W, N47F, and N47R. The remaining 29 data points
correspond to Fas mutations that significantly destabilize its
binding to one or both species of AChE.
We next examined how each of the tested Fas mutations
affects kinetic rates of binding. Interestingly, Fas binds to tAChE
and hAChE with different kinetics. The association rate of
WT Fas to tAChE is faster than its association to hAChE (6.8 3
107 M1 s1 and 5.1 3 106 M1 s1, respectively). However,
the dissociation rate ofWT Fas is also faster for tAChE compared
to hAChE (2.53102 s1 and 4.83 104 s1, respectively), thus
resulting in a 4-fold tighter Kd ofWT Fas to hAChE. Analysis of kon
data shows that it is significantly improved for two Fas mutants
(H29K and H29R) when binding to tAChE and for only one muta-
tion H29K when binding to hAChE (Figure 2B). Unchanged kon is
exhibited by a large number of mutants when binding to both
Table 1. Binding Parameters for Interactions between Fas Mutants and t/hAChE at Physiological Ionic Strength
Fas-taChE
Fas Mutant Kd (nM)
a kon, 3 10
7 (M1s1) koff 3 10
2 (s1)
Experimental
DDGbind (kcal/mol)
Calculated
DDGbind (kcal/mol)
WT 0.37 ± 0.07 6.80 ± 1.5 2.52 ± 0.90 0 0
8V 0.69 ± 0.12 5.17 ± 1.08 3.57 ± 1.01 0.37 ± 0.17 0.44
9I 0.25 ± 0.04 3.18 ± 0.82 0.796 ± 0.153 0.23 ± 0.17 0.043
9N 2.8 ± 0.2 NDb ND 1.19 ± 0.14 1.14
8V9I 0.780 ± 0.097 8.60 ± 0.47 0.671 ± 0.345 0.44 ± 0.15 0.76
8V9N 0.60 ± 0.05 8.50 ± 0.70 5.10 ± 0.05 0.28 ± 0.14 0.55
11K 0.63 ± 0.05 4.70 ± 0.40 2.96 ± 0.04 0.31 ± 0.14 0.25
12S 0.64 ± 0.05 7.50 ± 0.92 4.80 ± 0.458 0.32 ± 0.14 0.17
27F 22.6 ± 4.65 ND ND 2.43 ± 0.18 0.77
27M 33.2 ± 7.07 ND ND 2.65 ± 0.18 0.58
27Y 31.3 ± 9.05 ND ND 2.62 ± 0.21 0.94
29K 0.13 ± 0.03 19.6 ± 5.7 2.55 ± 0.824 0.62 ± 0.19 1.36
29R 0.03 ± 0.02 39.0 ± 3.5 1.17 ± 0.90 1.48 ± 0.41 1.48
32R 2.3 ± 0.2 3.50 8.05 1.08 ± 0.14 0.46
33F 1.8 ± 0.1 6.18 ± 2.19 11.1 ± 4.5 0.93 ± 0.14 1.98
33L 1.88 ± 0.02 0.197 ± 0.021 0.37 ± 0.14 0.96 ± 0.13 1.19
33Q 5.26 ± 0.49 0.309 ± 0.047 1.62 ± 0.21 1.57 ± 0.14 1.77
33Y 3.9 ± 1.3 4.63 ± 1.92 18.1 ± 8.0 1.39 ± 0.24 2.12
33W Unfc Unf Unf Unf 3.3
34N Unf Unf Unf Unf 0.71
34T 5.38 ± 1.16 3.33 ± 2.08 17.9 ± 7.8 1.58 ± 0.18 0.36
35R Unf Unf Unf Unf 0.13
35W 4.29 ± 0.05 1.92 ± 0.84 8.24 ± 1.19 1.44 ± 0.13 0.57
47F 0.85 ± 0.05 1.55 ± 0.01 1.34 ± 0.60 0.49 ± 0.14 1.24
47W 0.45 ± 0.03 1.19 ± 0.01 5.70 ± 0.30 0.11 ± 0.14 1.83
47R 0.150 ± 0.028 6.75 ± 0.85 1.03 ± 0.14 0.54 ± 0.09 2.55
Fas-hAChE Interactions
Fas Mutant Kd (nM)
a kon, 3 10
7 (M1s1) koff 3 10
2 (s1)
Experimental
DDGbind (kcal/mol)
Calculated
DDGbind (kcal/mol)
WT 0.094 ± 0.007 0.505 ± 0.022 0.0475 ± 0.0252 0 0
8V 0.64 ± 0.12 0.22 ± 0.11 0.143 ± 0.662 1.13 ± 0.12 0.86
9I 0.098 ± 0.013 0.426 ± 0.085 0.0417 ± 0.0116 0.024 ± 0.089 0.02
9N 41.7 ± 25.2 0.398 ± 0.19 16.6 ± 2.0 3.60 ± 0.36 2.31
8V9I 0.183 ± 0.031 0.200 ± 0.034 0.0366 ± 0.121 0.39 ± 0.11 0.68
8V9N 5.66 ± 0.35 0.583 ± 0.021 3.30 ± 1.18 2.42 ± 0.056 2.69
11K 0.27 ± 0.11 0.217 ± 0.106 0.0586 ± 0.012 0.62 ± 0.24 0.38
12S 0.31 ± 0.01 0.71 ± 0.17 0.220 ± 0.052 0.70 ± 0.046 0.10
27F 3.3 ± 1.3 0.49 ± 0.19 4.71 ± 0.29 2.49 ± 0.16 0.86
27M 1.15 ± 0.05 0.302 ± 0.059 0.347 ± 0.070 1.47 ± 0.05 1.02
27Y 5.37 ± 0.12 0.334 ± 0.108 1.79 ± 0.57 2.38 ± 0.04 1.04
29K 0.0210 ± 0.0014 0.892 ± 0.295 0.0187 ± 0.0075 0.88 ± 0.06 0.92
29R 0.0471 ± 0.0075 0.550 ± 0.160 0.0259 ± 0.0060 0.41 ± 0.10 0.27
32R 0.182 ± 0.038 0.442 ± 0.178 0.0796 ± 0.023 0.38 ± 0.13 0.30
33F 0.350 ± 0.036 0.245 ± 0.089 0.0858 ± 0.021 0.77 ± 0.07 0.20
33L 1.97 ± 0.14 0.344 ± 0.188 0.678 ± 0.341 1.79 ± 0.06 0.96
33Q 1.39 ± 0.33 0.0660 ± 0.0123 0.0917 ± 0.037 1.57 ± 0.15 1.90
33Y 0.31 ± 0.07 0.375 ± 0.0733 0.113 ± 0.013 0.68 ± 0.14 0.001
(Continued on next page)
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Table 1. Continued
Fas-hAChE Interactions
Fas Mutant Kd (nM)
a kon, 3 10
7 (M1s1) koff 3 10
2 (s1)
Experimental
DDGbind (kcal/mol)
Calculated
DDGbind (kcal/mol)
33W Unf Unf Unf Unf 0.65
34N Unf Unf Unf Unf 1.32
34T 0.73 ± 0.13 0.146 ± 0.054 0.106 ± 0.040 1.20 ± 0.11 0.67
35R Unf Unf Unf Unf 0.13
35W 0.85 ± 0.30 0.810 ± 0.357 0.689 ± 0.47 1.29 ± 0.21 1.30
47F 0.074 ± 0.002 0.460 ± 0.130 0.0345 ± 0.0004 0.14 ± 0.05 0.14
47W 0.10 ± 0.01 0.330 ± 0.030 0.0355 ± 0.0095 0.04 ± 0.05 0.48
47R 0.0893 ± 0.0042 0.427 ± 0.023 0.0380 ± 0.0003 0.01 ± 0.04 0.25
ND, not determined; Unf, unfolded.
aAll parameters were calculated from experiments shown in Figure S2. The experiments were repeated three times and SD was calculated.
bThe protein was not correctly folded after the refolding procedure as shown in Figure S1.
cThe value could not be determined due to very fast dissociation phase.
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this parameter compared to changes in kon. Eight mutations
were found to enhance koff for tAChE (T8V/T9I, T9I, H29R,
M33L, M33Q, N47F, N47W, and N47R) and two mutations for
hAChE (H29K and H29R; Figure 2C). On the other hand, for
several mutants, koff for hAChE was more than 50-fold faster
(worse) compared to WT Fas (T8V/T9N, T9N, R27F, R27Y, and
M33L).
We also examined whether some of the selected Fas mutants
display high specificity for one species of AChE over the other
species (e.g., at least 10-fold difference in binding affinity to
tAChE versus hAChE). As we mentioned before, WT Fas prefers
hAChE to tAChE by approximately a factor of four. Figure 2D
shows that two Fas mutants (T9N and T8V/T9N) exhibit reverse
binding specificity, binding to tAChE with 15- and 10-fold higher
affinity compared to hAChE. However, for both mutants the
specificity enhancement is achieved at the expense of reduced
binding affinity to both enzymes. In addition, we found four Fas
mutants (R27M,M33Y, K32R, and N47F) that show considerable
(>10-fold) preference for hAChE over tAChE. These results
demonstrate that in spite of very similar binding epitopes of
tAChE and hAChE, it is possible to find single and double Fas
mutants that show considerable preference toward one species
of the enzyme.
We next decided to investigate whether the Fas-AChE binding
landscape changes at low ionic strength where electrostatic in-
teractions are enhanced. At low ionic strength of I = 0.057 M,
binding affinity of WT Fas for both enzymes is reduced to
94 pM and 35 pM for tAChE and hAChE, respectively, in agree-
ment with previous experiments (Radic et al., 1997). Similarly,
affinities of all the tested Fas mutants are enhanced at low ionic
strength in comparison to physiological ionic strength (Table S2).
The increase in binding affinity at lower ionic strength comes
solely from an increase in kon, while koff remains virtually un-
changed in agreement with previous results on the Fas-mAChE
complex (Radic et al., 1997). The same data points, correspond-
ing to mutations H29R and H29K, exhibit significant enhance-
ment in binding affinity to both enzymes in comparison to WT
Fas. On average, we observed that DDGbind values at low ionic
strength were similar to those at physiological ionic strength,640 Structure 22, 636–645, April 8, 2014 ª2014 Elsevier Ltd All rightsthus indicating that the binding landscapes do not change
substantially.
Finally, to examine the accuracy of our computational protocol
for DDGbind predictions, we plotted all the experimentally
measured values of DDGbind versus computationally predicted
values and calculated the correlation between the two. For
measurements performed at physiological ionic strength, we
observed a correlation coefficient R = 0.70 between our predic-
tions and experimental results, attesting to the good accuracy of
our computational protocol that models only minimum flexibility
(Figure 3). A slightly worse correlation (R = 0.66) was observed
when comparing our predictions to experimental values ob-
tained at low ionic strength (Figure S3A). Interestingly, our pre-
dictions of DDGbind correlate much better with kon compared
to koff (R values of 0.61 and 0.15, respectively), indicating that
the success of DDGbind prediction comes mostly from the suc-
cess in predicting kon. We further compared our computational
results to those obtained by a more sophisticated method for
DDGbind prediction, CC/PBSA, that models backbone flexibility
by constructing a large ensemble of PPI structures and aver-
aging the DDGbind over the ensemble (Benedix et al., 2009).
The CC/PBSA calculations resulted in a considerably worse cor-
relation with our experimental results (R = 0.45) while requiring
significantly longer time for completion (Figure S3B). In addition,
the CC/PBSA method did not predict enhancement in binding
affinity for any of the Fas mutants that showed significant affinity
enhancement experimentally.
DISCUSSION
Optimality of the Fas Binding Interface and Interfaces of
Other High-Affinity PPIs
We expected that the Fas-AChE interface is already evolutionary
optimized, with its WT amino acid sequence lying near the opti-
mum of the fitness landscape. Thus, the majority of mutations in
this interface should lead to large destabilization of the complex,
while neutral and beneficial mutations in the direct binding
interface should be rare, making our task of finding such
mutations a challenge. Previous mutational studies on Fas in
complex with murine AChE (mAChE) demonstrated that veryreserved
Figure 3. Correlation between the Experimental and the Calculated
DDGbind for Fas Mutant-t/hAChE Interactions
Experimental measurements were performed at ionic strength of 0.15 M. The
calculated values of DDGbind were obtained using a computational saturated
mutagenesis protocol that models only side chain flexibility as described in the
Experimental Procedures. The data are fitted to a linear equation Y = 0.29 +
0.72 X, with an R value of 0.70.
Figure 4. Histogram Showing the Distribution of Mutations accord-
ing to Their Effect on PPI Binding Energetics
Light gray histogram corresponds to experimental measurements in various
high-affinity PPIs (Kd < 1 nM) compiled from the SKEMPI database (Moal
and Fernandez-Recio, 2012). Dark gray histogram corresponds to com-
putational predictions of mutational effects in the Fas-t/hAChE complexes
reported in this work. Black histogram corresponds to experimental mea-
surements of mutational effects in the Fas-t/hAChE interactions presented in
this work.
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mutating only one or a few key residues on the AChE side
(DDGbind of 3–5 kcal/mol for single mutants and 11 kcal/mol for
a triple mutant; Radic et al., 1994). Our experimental results
also show destabilization of more than 2 kcal/mol for 7 data
points and more than 1 kcal/mol for 21 of 44 measured data
points, revealing the steepness of the fitness landscape in the
vicinity of the WT Fas sequence.
To make a more general comparison of the Fas-AChE binding
landscape with binding landscapes of other high-affinity PPIs,
we turned to the SKEMPI database that contains more than
3,000 binding affinity measurements for various PPI mutants
(Moal and Fernandez-Recio, 2012). Using this database, we
constructed a histogram for experimentally measured DDGbind
values for single mutants in high-affinity PPIs (Kd < 1 nM; 1,205
data points), thus exploring various single moves in the se-
quence space starting from the WT binding interface sequence
of high-affinity complexes (Figure 4). We generated a similar his-
togram using our computational predictions of DDGbind values in
the Fas-t/hAChE complexes and another histogram for experi-
mentally measured DDGbind values at the physiological ionic
strength reported in this work (Figure 4). Figure 4 shows that
the distribution of DDGbind values for various high-affinity PPIs
is not symmetrical, revealing a much higher probability of finding
a deleterious mutation at the binding interface compared to
a beneficial mutation. This distribution exhibits a mean of
1.45 kcal/mol, an SD of 1.97 kcal/mol, and a long righthand
side tail corresponding to mutations that substantially decrease
affinity. Yet, affinity-enhancing mutations are not extremely rare
for high-affinity PPIs with 20% of all mutations exhibiting
DDGbind < 0 kcal/mol and 9% of mutations exhibiting DDGbind <
0.5 kcal/mol. A histogram resulting from our predictions of
DDGbind values in the Fas-t/hAChE interactions is very similarStructure 22to that observed for various high-affinity PPIs with a mean of
1.58 kcal/mol and an SD of 2.25 kcal/mol. Among Fasmutations,
17% are predicted to result in DDGbind < 0 kcal/mol and 7% of
mutations to result in DDGbind < 0.5 kcal/mol. The histogram
of experimentally measured DDGbind values for the Fas-t/hAChE
interactions includes only a subset of all possible mutations, yet
covers almost the full range of computationally predicted values
with 16% of mutations resulting in DDGbind < 0 kcal/mol and 8%
of mutations resulting in DDGbind < 0.5 kcal/mol. In summary,
the above results show that the Fas binding landscape is similar
to binding landscapes of other high-affinity PPIs where the
majority of point mutations in the binding interface lead to
moderate destabilization of the complex, a considerable amount
of mutations lead to high destabilization of the complex, and
the minority of mutations lead to moderate stabilization of the
complex.
Computational binding landscapes are not only helpful for
understanding evolution of the whole binding interface, but
also reveal a degree of optimality at different binding interface
positions. Our analysis shows that many of the Fas positions
are already occupied by the best amino acid choice. This is
especially true for hAChE, which exhibits higher affinity to Fas
compared to tAChE. For example, no better amino acid
(compared toWT) could be found at 7 of 13 positions when inter-
acting with hAChE (Figure 1B). Nevertheless, our computational
scan also revealed that a few positions at the Fas binding
interface are less optimized than others, such as positions 29
and 47 (Figure 1B), where further improvement is possible
through a number of mutations. Indeed, at these positions,
affinity-enhancing mutations were found experimentally. This
finding suggests that more permissive positions in any PPI are, 636–645, April 8, 2014 ª2014 Elsevier Ltd All rights reserved 641
Figure 5. Structural Analysis of the Affinity-
Enhancing Mutations
(A and B) Fas is shown in cyan and t/hAChE in
green. H29R and H29K and their interactions with
tAChE (A) and with hAChE (B) according to our
modeling. WhereasWT His at position 29 does not
make any contacts with either tAChE or hAChE
(left panels), Arg at this position forms two
hydrogen bonds with either Asp 285 on tAChE or
Glu 292 on hAChE (middle panels). The hydrogen
bonds are predicted to be more energetically
favorable for tAChE compared to hAChE. Lys29
forms a hydrogen bond with the backbone of
tAChE and forms two hydrogen bonds with side
chains of Glu 292 and Gln 291 on hAChE (right
panels).
(C) N47R and its interactions with tAChE. Whereas
WT Asn at position 47 is too far to form any inter-
molecular interactions (left panel), upon mutation
to Arg, a new salt bridge with Glu 247 on tAChE is
created (middle panel).
Structure
Binding Landscapes of High-Affinity PPIsgood targets for engineering affinity-enhancing mutations either
through computational or combinatorial means.
Among a large but not exhaustive number of experimentally
tested mutations we found three, H29R, H29K, and N47R, that
significantly improve binding affinity to either both or one enzyme
and three mutations that slightly improve affinity to one enzyme
(T9I, N47W, and N47F). The three mutations with significantly
improved affinity are polar and positively charged. This is in
contrast to most of the previous design studies that focused
on finding hydrophobic affinity-enhancing mutations (Sammond
et al., 2007; Haidar et al., 2009). The improvement in affinity for
H29R and H29K is due to improvement in both kon and koff.
Structural analysis showed that the WT His at position 29 does
not participate in any intermolecular interactions with tAChE/
hAChE. Mutation of His to either R or K improves electrostatic
interaction with the enzyme (resulting in kon enhancement) and
creates direct hydrogen bonds with the enzyme. Interestingly,
the two very similar mutations prefer different enzyme species.
Whereas K at this position is more optimal for interaction with
hAChE, R at the same position makes better contacts with
tAChE (Figures 5A and 5B). The third affinity-improving mutation,
N47R, also occurs at a position whereWT Asn is too far to partic-
ipate in any intermolecular interactions. Mutating it to Arg intro-
duces a new salt bridge to Glu 247 on tAChE (Figure 5C).
The magnitude of the affinity enhancement reported here for
single mutations is larger than that obtained in a similar study
for a picomolar antibody-antigen complex (Lippow et al.,
2007). The small number of identified affinity-enhancing muta-
tions for the Fas-AChE PPI is not surprising because the Fas
interface is very small, consisting of only 13 positions. Large in-
terfaces, such as those of antibody-antigen complexes, have a
potential for greater number of affinity-enhancing mutations,
combination of which could lead to several orders of magnitude
enhancement in affinity.642 Structure 22, 636–645, April 8, 2014 ª2014 Elsevier Ltd All rights reservedThree of the tested Fas mutants failed
to refold using the standard refolding
protocol (M33W, V34N, and L35R). For
all three mutants, the predicted negativeDDGbind was coupled to high destabilization of the Fas chain
in the unbound form (Table S1). These results demonstrate
that a certain percentage of single mutations are not compatible
with folded proteins and hence cannot be used for generation of
binding landscapes. Indeed, some experimental binding affinity
measurements with high positive DDGbind values might corre-
spond to instances where the protein mutant is mostly unfolded.
Hence, the criteria for designing affinity-enhancing mutations
should be based not only on negative DDGbind, but also on
neutral or stabilizing effect of the mutation on the unbound
chain.
Kinetics of Binding and Its Evolutionary Consequences
Our measurements revealed substantial differences in associa-
tion and dissociation rates between Fas and the two enzyme
species, demonstrating that high affinity could be achieved
through different kinetics. While both association and dissocia-
tion is fast for tAChE, both processes are slower for hAChE.
These differences in kinetics might be due to slight variation
in the enzyme interface composition. hAChE contains more
hydrophobic and aromatic residues compared to that of
tAChE (with eight hydrophobic and seven aromatic residues
on hAChE versus six hydrophobic and five aromatic residues
on tAChE). On the contrary, the tAChE binding interface is
more charged relative to that of hAChE (five negatively charged
and one positively charged residue for tAChE versus three
negatively charged residues and two positively charged for
hAChE). The more polar and charged nature of the tAChE
interface could explain faster association driven by long-range
electrostatics and faster dissociation due to fewer hydrophobic
contacts. Interestingly, the hAChE binding interface is very
similar to that of mAChE (90% sequence identity), which is
Fas target in nature (because Green Mamba snakes prey on
rodents). The kinetic rates of the Fas-mAChE interactions at
Table 2. Kinetic Parameters for Exemplary High-Affinity PPIs
PPI kon (M
1 s1) koff (s
1)
Fas/tAChE 6.8 3107a 2.5 3102a
Fas/hAChE 5.1 3106a 4.8 3104a
Fas H29R/tAChE 3.9 3108a 1.2 3102a
Barstar/Barnase 3.7 3108b 3.7 3106b
Interleukin 4/interleukin 4 receptor 1.3 3107b 2.1 3103b
Colicin E9/colicin E9 DNase 6.5 3107b 3.5 3105b
Trypsin/BPTI 9.9 3105b 5.0 3108b
aThe values were measured in this work.
bTaken from the SKEMPI database.
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Binding Landscapes of High-Affinity PPIsthe same conditions were estimated to be 8 3 106 M1 s1
and 1 3 104 s1 (Radic et al., 1997), respectively, similar
to those of the Fas-hAChE interactions. Slower association
and dissociation rates of Fas to mAChE and hAChE result
in longer inhibition of the enzyme and greater physiological
consequences.
Compared to other high-affinity PPIs, Fas-AChE interactions
are characterized by optimal kon but mediocre koff. Indeed,
kon of the Fas-tAChE interactions is higher than that of most
other high-affinity PPIs (Table 2), whereas kon of the Fas
H29R mutant toward tAChE is the same as that of one of
the fastest PPIs in nature, the barnace/barstar complex. On
the other hand, koff of Fas interactions with hAChE and partic-
ularly with tAChE is much worse than those of other high-
affinity complexes and can be compared only to that of the
interleukin 4/interleukin 4 receptor complex. Interestingly, koff
of the trypsin/BPTI complex, which is also a complex between
an enzyme and a small disulfide-bonded inhibitor, is several
orders of magnitude slower than that of the Fas-AChE
interactions.
Despite these results, we found that both kon and koff of Fas-
AChE interactions could be further enhanced through mutations
with equal probability. However, sometimes enhancement in one
parameter leads to a compromise in the other, resulting in no
improvement in Kd. Mutations that were identified here to
improve kon were all polar in nature and improve long-range elec-
trostatics as in some previous design studies (Selzer et al., 2000).
Both polar and hydrophobic mutations were identified to
improve koff, resulting in larger burial of the hydrophobic surface
area and creation of new hydrogen bonds.
In conclusion, we explored binding landscapes of two homol-
ogous high-affinity complexes using both computational and
experimental means and demonstrated that the two landscapes
are typical for high-affinity PPIs. We showed that the sequence
of one binding partner (Fas) is close to optimum when interact-
ing with its targets (tAChE and especially hAChE). However,
mutations at positions that presently are not involved in
intermolecular interactions resulted in further improvement of
fitness. We showed that kinetics of binding could be quite
different for two homologous PPIs, and both association and
dissociation rates could be further enhanced through mutations.
Last of all, we demonstrated that binding landscapes in PPIs
could be well approximated by computational landscapes pro-
duced by a simple protocol for the DDGbind prediction presented
in this work.Structure 22EXPERIMENTAL PROCEDURES
In Silico Saturated Mutagenesis of the Fas-AChE Interface
The residues on Fas that are within 4 A˚ of tAChE/hAChE in the Fas-tAChE/Fas-
hAChE complex structures (Kryger et al., 2000; Harel et al., 1995) were defined
as Fas binding interface (positions 6, 8, 9, 11, 12, 27, 29, 32, 33, 34, 35, 47, and
61). For each of the binding interface position, we define a set of shell positions
including the residues on tAChE/hAChE that are within 4 A˚ from the considered
Fas position and the residues on Fas that are within 3 A˚ from the considered
position. For each binding interface position, we then perform 18 calculations,
when the considered position on Fas is either kept WT or is replaced with
another amino acid, all except for Pro, Cys, and Gly. During the calculation,
the shell and the interface residues are repacked, and the energy of the Fas-
AChE complex is calculated for the WT and for the mutated complex. We
then separate the two chains and calculate the energy of each unbound chain
separately either without further repacking of the side chains or with repacking
(as stated in the text). The intermolecular energy was calculated by subtracting
the energies of the single chains (Fas and AChE) from the total energy of the
complex. DDGbind is calculated as the intermolecular energy of the mutant
subtracted by the intermolecular energy of the WT complex. Finally, the ob-
tained DDGbind was normalized according to a linear equation obtained in
our previous work where the correlation between various experimental and
computed DDGbind values were tested (see Figure 3F in Sharabi et al.,
2011). Rotamer libraries used for design were based on the backbone-depen-
dent library of Dunbrack and Karplus (Dunbrack and Karplus, 1993) with
additional rotamers expanded by 1 SD around their mean c1 and c2 values.
For the calculations, we used ORBIT software with the energy function
optimized by our group for design of protein-protein interactions (Sharabi
et al., 2011). The lowest-energy rotameric conformation of each mutant was
found using the Dead-End Elimination theorem (Desmet et al., 1992; Gordon
et al., 2003). All optimizations were performed using a cluster of Xeon
computers.
Fas Mutant Construction
Gene constructs for Fas mutants were constructed from the WT Fas gene
using either the standard site-directed mutagenesis procedure or the
Transfer-PCR (TPCR) procedure (Erijman et al., 2011). WT Fas and mutants
were expressed in E. coli BL21 cells and refolded from inclusion bodies using
a protocol reported in our previous work (Sharabi et al., 2009). The success of
refolding was verified by checking the concentration of free thiols, by gel filtra-
tion chromatography, and for some mutants by performing Circular Dichroism
measurements (see Figure S1 for details).
Enzyme Preparations
Both enzymes tAChE and hAChE were gifts form Prof. Israel Silman. Whereas
tAChE was purified from the electric organ tissue of T. californica (Sussman
et al., 1988), hAChE was expressed recombinantly.
Measurement of the Kinetic and Thermodynamic Parameters for
Fas-AChE Interactions
The equilibrium binding affinity and kinetic rates between Fas mutants and
t/hAChE were measured by performing the enzyme activity assay using the
colorimetric detection of AChE product in the presence and the absence of
Fas inhibitor at conditions where binding between the two proteins ap-
proaches equilibrium (Sharabi et al., 2009). For this purpose, mixtures of
AChE at 0.02 nM and of a Fas variant in at least 10-fold excess over the
AChE concentration were pre-incubated with 0.6mMof 5,50-dithiobis-(2-nitro-
benzoic acid) (DTNB) for a variable period of time in a 50 mM phosphate
buffer containing 0.1 mg/ml BSA and 0.025% NaN3 at pH 8.0 (ionic strength
of 0.15 M) and for low ionic strength experiments in the 20 mM phos-
phate buffer containing 0.1 mg/ml BSA and 0.025% NaN3 at pH 8.0 (ionic
strength of 0.057 M). AChE enzymatic reaction was initiated by the addition
of the AChE substrate acetylthiocholine iodide (ATC) at 1 mM. When ATC is
cleaved by AChE, it reacts with DTNB, producing absorbance at 412 nm.
Hence, AChE activity was measured by monitoring the absorbance increase
at 412 nm over 1 min. The percent of AChE activity for the sample pre-incu-
bated with Fas for a certain time was calculated by dividing the measured
AChE activity of the sample by that of the sample containing AChE in the, 636–645, April 8, 2014 ª2014 Elsevier Ltd All rights reserved 643
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Binding Landscapes of High-Affinity PPIsabsence of Fas. The data were fit to the following equation to determine kon,
koff, and Kd:
%activity= 100

Kd
½Fas+Kd

+
 ½Fas
½Fas+Kd expð  tkonð½Fas+KdÞÞ

;
(Equation 1)
where [Fas] is Fas concentration and t is the pre-incubation time (Figure S2).
For derivation of this equation, see Laidler, 1987. Each experiment was per-
formed at least three times and an average and SD were calculated.
Analysis of Mutational Effects on Binding in Various High-Affinity
PPIs
Mutational data for high-affinity complexes were downloaded from the
SKEMPI database. The data set incorporated single mutations in the following
Protein Data Bank (PDB) numbers: 1CSE, 1ACB, 1TM1, 1SIC, 1IAR, 1EMV,
1BRS, 1JTG, 2O3B, 2J0T, 1MAH, 1EAW, 3BN9, 3NPS, 2FTL, 1Z7X, 1A4Y,
1DAN, 3HFM, 1CHO, 1PPF, 1R0R, and 3SGB. The data contained 1,205
mutations, 17% (205) of which were mutations to Ala. DDGbind values were
calculated from the Kds of the mutant and WT proteins and a histogram of
these values was plotted on Figure 4. Due to uncertainties in measuring and
predicting very large destabilizing DDGbind values, we introduced a cutoff of
6 kcal/mol for both experimental and computational data.
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